Mandarin Translations

Transcription

1 British Journal of Pharmacology DOI:0./j x To cite any of the articles below, please refer to the full article and not the DOI of this translations section. b 2 -adrenoceptor agonists: current and future direction Mario Cazzola, Luigino Calzetta 2 and Maria Gabriella Matera 3 Unit of Respiratory Clinical Pharmacology, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy, 2 IRCCS SanRaffaele Pisana, Rome, Italy, and 3 Unit of Pharmacology, Department of Experimental Medicine, Second University of Naples, Naples, Italy To view the full version of this article please visit The Authors British Journal of Pharmacology 20 The British Pharmacological Society i

2 New perspectives regarding b 2 -adrenoceptor ligands in the treatment of asthma JKL Walker, RB Penn 2, NA Hanania 3, BF Dickey 4 and RA Bond 5 Department of Medicine, Duke University Medical Center, Durham, NC, USA, 2 Department of Medicine, University of Maryland, Baltimore, MD, USA, 3 Department of Medicine, Baylor College of Medicine, Houston, TX, USA, 4 Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA, and 5 Department of Pharmacology and Pharmaceutical Sciences, University of Houston, Houston, TX, USA To view the full version of this article please visit Glucocorticosteroids: current and future directions Peter J Barnes National Heart & Lung Institute, Imperial College, London, UK To view the full version of this article please visit ii

3 BJP Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD Bart C Moulton and Allison D Fryer Division Pulmonary and Critical Care Medicine, Oregon Health Sciences University, Portland, OR, USA To view the full version of this article please visit Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease Klaus F. Rabe Department of Medicine, University Kiel, Germany and Krankenhaus Grosshansdorf, Center for Pulmonology and Thoracic Surgery, Grosshansdorf, Germany To view the full version of this article please visit iii

4 Does airway smooth muscle express an inflammatory phenotype in asthma? Gautam Damera and Reynold A Panettieri, Jr,2 Airways Biology Initiative, Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA, and 2 Center of Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, PA, USA To view the full version of this article please visit Cytokine/anti-cytokine therapy novel treatments for asthma? Philip M Hansbro, Gerard E Kaiko and Paul S Foster Centre for Asthma and Respiratory Disease and Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia To view the full version of this article please visit iv

5 BJP Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies Ma en Obeidat and Ian P. Hall Division of Therapeutics and Molecular Medicine, Nottingham Respiratory Biomedical Research Unit, University of Nottingham, Nottingham, UK To view the full version of this article please visit Is a regenerative approach viable for the treatment of COPD? Matthew Hind and Malcolm Maden 2 Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, Dovehouse St, London, UK, and 2 Department of Biology & UF Genetics Institute, Bartram Hall, University of Florida, Gainesville, FL, USA To view the full version of this article please visit v

6 Cough: an unmet clinical need Peter V. Dicpinigaitis Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA To view the full version of this article please visit New perspectives for the treatment of pulmonary hypertension Reshma S Baliga, Raymond J MacAllister 2 and Adrian J Hobbs,2 Department of Pharmacology, University College London, London, UK, and 2 Department of Clinical Pharmacology, University College London, London, UK To view the full version of this article please visit vi

7 BJP Novel therapeutic approaches for pulmonary fibrosis Arnab Datta, Chris J Scotton and Rachel C Chambers Centre for Respiratory Research, University College London, Rayne Institute, London, UK To view the full version of this article please visit New horizons in the treatment of cystic fibrosis AW Cuthbert Department of Medicine, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK To view the full version of this article please visit vii

8 Novel classes of antibiotics or more of the same? Anthony RM Coates, Gerry Halls 2 and Yanmin Hu Medical Microbiology, Centre for Infection, Department of Clinical Sciences, St George s, University of London, Cranmer Terrace, London, UK and 2 Medical Marketing Services, Beaconsfield, Buckinghamshire, UK To view the full version of this article please visit Inhaled innate immune ligands to prevent pneumonia Scott E Evans, Michael J Tuvim, Cory J Fox, Nidhi Sachdev, Leonid Gibiansky 2 and Burton F Dickey Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, and 2 QuantPharm, LLC, North Potomac, MD, USA To view the full version of this article please visit viii